20
Pfizer Inc. New York City Us, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Estradiol hemihydrate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1997-123 - Rev 01
This Chemical Type CEP, issued on February 16, 2009, remains in force until September 10, 2020, ensuring its reliability within the pharmaceutical industry.
Substance Number 821 associated with this CEP further emphasizes